rting programs sponsored by the Food and Drug Administration (FDA) of the Department of Health and Human Services (DHHS). • Institutions will use the Adverse Drug Reaction Monitoring and Prevention Program outlined in the Pharmacy TRM. • Drug product defects will be reported in accordance with the FDA drug product problem repo